0
0
8/23/22 at 7:03pm
Organization
Hospitalhealth.com.au
30 words
0
Comments
Immunisations providing protection against deadly respiratory syncytial virus (RSV) could be accessible on the market within 12 months.
You are the first to view
https://www.hospitalhealth.com.au/content/clinical-services/news/rsv-prevention-could-be-be-within-reach-research-1091113111
Create an account
or login to join the discussion